bioRxiv Science⌕ Search

Biology subjects

Robinson, R. T.

Publications and source records attributed to Robinson, R. T..

2 recordsLinked to original sources

Mycobacterium intracellulare ABSURDO is a novel clinical isolate with three colony morphotypes that vary in pathogenicity and sequence at the PKS and MtrA loci

Mycobacterium intracellulare is a nontuberculous mycobacteria (NTM) species which can cause serious and sometimes fatal disease in immunocompromised individuals. Other NTM species, including M. avium and M. abscessus, commonly exhibit two colony morphotypes (smooth and rough) which vary in appearance and liquid growth properties. Here we characterize a novel clinical isolate of M. intracellulare which exhibits three (not two) colony morphotypes which differ in appearance, liquid growth properties, acid-fastness and in vivo survival following infection of mice via an inhalational exposure model. The genome of this isolate, which we have termed ABSURDO, as well as the genome of each morphotype components, aligns with that of M. intracellulare yet contains [~]16% more protein coding sequences than the M. intracellulare type strain ATCC 13590T. Variation analysis of each morphotype genome revealed that across the three morphotypes there were only two mutations which had a high likelihood of causing a phenotype due to a genetic change: one in the gene encoding modular polyketide synthase (PKS), and another in the two component system response regulator MtrA. Neither of these genes have been previously implicated in the morphotype shifting of an NTM. In summary, M. intracellulare ABSURDO is a novel pathogenic isolate with a genome that aligns with (but is nevertheless larger than) the M. intracellulare type strain and comprises three morphotype components which differ in two genes that have not been implicated in NTM appearance, acid-fastness, in vitro and in vivo growth.

microbiology↗

A role for Toll-like receptor 3 in lung vascular remodeling associated with SARS-CoV-2 infection

Cardiovascular sequelae of severe acute respiratory syndrome (SARS) coronavirus-2 (CoV-2) disease 2019 (COVID-19) contribute to the complications of the disease. One potential complication is lung vascular remodeling, but the exact cause is still unknown. We hypothesized that endothelial TLR3 insufficiency contributes to lung vascular remodeling induced by SARS-CoV-2. In the lungs of COVID-19 patients and SARS-CoV-2 infected Syrian hamsters, we discovered thickening of the pulmonary artery media and microvascular rarefaction, which were associated with decreased TLR3 expression in lung tissue and pulmonary artery endothelial cells (ECs). In vitro, SARS-CoV-2 infection reduced endothelial TLR3 expression. Following infection with mouse-adapted (MA) SARS-CoV-2, TLR3 knockout mice displayed heightened pulmonary artery remodeling and endothelial apoptosis. Treatment with the TLR3 agonist polyinosinic:polycytidylic acid reduced lung tissue damage, lung vascular remodeling, and endothelial apoptosis associated with MA SARS-CoV-2 infection. In conclusion, repression of endothelial TLR3 is a potential mechanism of SARS-CoV-2 infection associated lung vascular remodeling and enhancing TLR3 signaling is a potential strategy for treatment.

molecular biology↗